Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
24.56
-0.13 (-0.53%)
Oct 2, 2026, 4:00 PM EDT - Market closed
THNR Holdings Information
THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Eli Lilly and Company stock at 10.19%, Novo Nordisk at 8.45%, CSPC Pharmaceutical Group at 5.92%, Amgen at 5.65%, and Pfizer at 5.40%.
Total Holdings
23
Top 10 Percentage
60.09%
Asset Class
Equity
ETF Category
Health
Assets
5.64M
PE Ratio
19.01
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.19% |
| 2 | NVO | Novo Nordisk A/S | 8.45% |
| 3 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.92% |
| 4 | AMGN | Amgen Inc. | 5.65% |
| 5 | PFE | Pfizer Inc. | 5.40% |
| 6 | HKG: 1801 | Innovent Biologics, Inc. | 5.39% |
| 7 | LON: AZN | AstraZeneca PLC | 5.24% |
| 8 | SWX: ROP | Roche Holding AG | 4.66% |
| 9 | ABBV | AbbVie Inc. | 4.61% |
| 10 | MRK | Merck & Co., Inc. | 4.58% |
| 11 | REGN | Regeneron Pharmaceuticals, Inc. | 4.58% |
| 12 | GILD | Gilead Sciences, Inc. | 4.58% |
| 13 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 4.55% |
| 14 | VKTX | Viking Therapeutics, Inc. | 4.34% |
| 15 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.04% |
| 16 | AGPXX | Invesco Shrt-Trm Inv Gov&Agcy Instl | 3.94% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 3.74% |
| 18 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 3.56% |
| 19 | GPCR | Structure Therapeutics Inc. | 3.11% |
| 20 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.41% |
| 21 | KLRA | Kailera Therapeutics, Inc. | 0.97% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.08% |
| 23 | n/a | US DOLLARS | 0.00% |
As of Oct 1, 2026